摘要
目的探讨彩色多普勒超声在新辅助化疗治疗乳腺癌疗效评价中的特点和应用价值。方法应用彩色多普勒超声对新辅助化疗前后乳腺癌癌肿的声像图指标改变进行观察,并以病理组织学评价为标准,评估超声评价的疗效符合率。结果超声评价符合率高达88.7%(94/106)。结论彩色多普勒超声评价准确、简捷、有效,对准确评估新辅助化疗疗效、指导临床制定个体化乳腺癌治疗方案具有重要价值。
Objective To investigate the features and value of neoadjuvant chemotherapy for breast cancer treatmentevaluation by color doppler ultrasound. Methods A total of 106 cases of breast cancer patients treated by neoadjuvantchemotherapy （ET） program were checked with color doppler ultrasound before and after breast cancer chemotherapy. Ultrasonographic indicators changes were observed to compare the evaluation of palpation and ultrasound evaluation ofthe efficacy of line rate. Results Ultrasound evaluation of compliance rate was 88.7% （94/106）. Conclusion The evaluation of color doppler ultrasound is accurate, simple, effective and has significant value to guide the clinical development of individualized breast cancer treatment.
出处
《中国现代医生》
2013年第22期65-66,69,共3页
China Modern Doctor
关键词
新辅助化疗
乳腺癌
彩色多普勒超声
评价
Neoadjuvant chemotherapy
Breast cancer
Color doppler ultrasound
Evaluation
